Clinical trial
Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.
NCT07380022 is registered in ClinicalTrials.gov with University of Thessaly as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.
- Lead sponsor
- University of Thessaly
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 9, 2025
- Completion date
- February 28, 2026
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, colitis ulcerative, hypertension (htn), ibd, multiple sclerosis